Interpreting blood eosinophil counts in health and obstructive lung disease

Yunus Çolak, Peter Lange

Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yunus Çolak, Peter Lange. Interpreting blood eosinophil counts in health and obstructive lung disease. Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood eosinophils and obstructive lung disease in the general population
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Platelets count in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018



Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016


The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010

Stability of eosinophils in blood in patients with chronic obstructive pulmonary diseasee (COPD) and one hospital admission
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008


Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Peripheral eosinophil count as a biomarker for the management of COPD: not there yet
Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017
Year: 2017